Safety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trialPerry B. Shieh, Salvador Rico, Astrid Blaschek et al.|The Lancet Neurology|2023Cited by 120
A multicenter, retrospective medical record review of X‐linked myotubular myopathy: The recensus studyAlan H. Beggs, Suyash Prasad, Barry J. Byrne et al.|Muscle & Nerve|2017Cited by 83
Skeletal Muscle Pathology in X-Linked Myotubular Myopathy: Review With Cross-Species ComparisonsMichael W. Lawlor, Caroline A. Sewry, Alan H. Beggs et al.|Journal of Neuropathology & Experimental Neurology|2016Cited by 66
Mortality and respiratory support in X-linked myotubular myopathy: a RECENSUS retrospective analysisRobert J. Graham, Alan H. Beggs, Francesco Muntoni et al.|Archives of Disease in Childhood|2019Cited by 43